Cargando…

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

BACKGROUND: Pancreatic adenocarcinomas (PAs) have very poor prognoses even when surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival in patients with PA. The aims of this study were to (1) describe the metabolome of pancreatic parenchyma (PP) and PA, (2) det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battini, S., Faitot, F., Imperiale, A., Cicek, A. E., Heimburger, C., Averous, G., Bachellier, P., Namer, I. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353864/ https://www.ncbi.nlm.nih.gov/pubmed/28298227 http://dx.doi.org/10.1186/s12916-017-0810-z

Ejemplares similares

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases
por: Imperiale, Alessio, et al.
Publicado: (2019)

Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy
por: Addeo, Pietro, et al.
Publicado: (2022)

Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications()()
por: Imperiale, Alessio, et al.
Publicado: (2015)

FDG-PET/CT findings of atypical (bizarre/symplastic) uterine leiomyoma in a patient with abdominal leiomyosarcoma
por: Hubelé, Fabrice, et al.
Publicado: (2015)

Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches
por: Hescot, Ségolène, et al.
Publicado: (2017)

A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas
por: Imperiale, Alessio, et al.
Publicado: (2013)

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Mahajan, Ujjwal Mukund, et al.
Publicado: (2021)

Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy
por: Ben Sellem, D., et al.
Publicado: (2011)

Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma
por: Unger, Keith, et al.
Publicado: (2018)

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
por: Debien, Véronique, et al.
Publicado: (2021)

Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
por: Elebo, Nnenna, et al.
Publicado: (2021)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Macias, Rocio I.R., et al.
Publicado: (2020)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018)

Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
por: Carvalho, Tiago M. A., et al.
Publicado: (2021)

Metabolomic approach to profile functional and metabolic changes in heart failure
por: Deidda, Martino, et al.
Publicado: (2015)

PiDeeL: metabolic pathway-informed deep learning model for survival analysis and pathological classification of gliomas
por: Kaynar, Gun, et al.
Publicado: (2023)

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
por: Amantini, Consuelo, et al.
Publicado: (2019)

Comparison of preoperative imaging and pathological findings for pancreatic head adenocarcinoma: A retrospective analysis by the Association Française de Chirurgie
por: Gilabert, Marine, et al.
Publicado: (2017)

Omics Approaches in Pancreatic Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2019)

Integrative analysis of metabolome and gut microbiota in Patients with pancreatic ductal adenocarcinoma
por: Guo, Xiaodong, et al.
Publicado: (2022)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics
por: Tan, Cong, et al.
Publicado: (2022)

MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?
por: Anderson, Mark A., et al.
Publicado: (2023)

Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma
por: Rho, Seoung Yoon, et al.
Publicado: (2019)

Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma
por: Zhou, Tianxing, et al.
Publicado: (2023)

Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination
por: Itoi, Takao, et al.
Publicado: (2017)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

(64)CuCl(2) PET Imaging of 4T1-Related Allograft of Triple-Negative Breast Cancer in Mice
por: Latgé, Adrien, et al.
Publicado: (2022)

Open and Minimal Approaches to Pancreatic Adenocarcinoma
por: Bhogal, Ricky H., et al.
Publicado: (2020)

Distinct serum metabolomics profiles associated with malignant progression in the Kras(G12D) mouse model of pancreatic ductal adenocarcinoma
por: LaConti, Joseph J, et al.
Publicado: (2015)

The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018)

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
por: Braun, Lukas M., et al.
Publicado: (2020)

Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma
por: Chaika, Nina V., et al.
Publicado: (2012)

Targeting cancer cell metabolism in pancreatic adenocarcinoma
por: Cohen, Romain, et al.
Publicado: (2015)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
por: Li, Hongzhe, et al.
Publicado: (2017)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_imc2qhjlmgis38pro5l6m1if5a